CAS No. |
2374124-49-7 |
中文名称 |
(13S)-26-(3-(2-(二螺[2.0.24.13]庚烷-7-基)乙氧基)-1H-吡唑-1-基)-15,15-二甲基-61,62-二氢-5-硫杂-4,7-二氮杂-2(2,3),6(6,2)-二吡啶并-1(1,3)-吡咯烷环癸番-3-酮 5,5-二氧化物 |
英文名称 |
(13S)-26-(3-(2-(dispiro[2.0.24.13]heptan-7-yl)ethoxy)-1H-pyrazol-1-yl)-15,15-dimethyl-61,62-dihydro-5-thia-4,7-diaza-2(2,3),6(6,2)-dipyridina-1(1,3)-pyrrolidinacyclodecaphan-3-one 5,5-dioxide |
别名 |
13H-17,20-Methano-8,12-nitrilo-12H-pyrido[3,2-d][1,2,6,13]thiatriazacyclooctadecin-5(6H)-one, 2-[3-(2-dispiro[2.0.2.1]hept-7-ylethoxy)-1H-pyrazol-1-yl]-14,15,16,17,18,19-hexahydro-19,19-dimethyl-, 7,7-dioxide, (17S)-;Vanzacaftor;Vanzacafter;Vanzacaftor (Synonyms: VX-121) |
标准英文名 |
(13S)-26-(3-(2-(dispiro[2.0.24.13]heptan-7-yl)ethoxy)-1H-pyrazol-1-yl)-15,15-dimethyl-61,62-dihydro-5-thia-4,7-diaza-2(2,3),6(6,2)-dipyridina-1(1,3)-pyrrolidinacyclodecaphan-3-one 5,5-dioxide |
分子式 |
C32H39N7O4S |
分子量 |
617.28
|
精确分子量 |
617.28
|
SMILES |
CC(C)(C[C@@](CCC/N=C1NC(S(=O)(N2)=O)=CC=C\1)([H])C3)N3C4=NC(N(C=C5)N=C5OCCC6C7(CC7)C68CC8)=CC=C4C2=O |
标准SMILES |
CC1(C)C[C@@H]2CCCN=C3C=CC=C(N3)S(=O)(=O)NC(=O)C3=CC=C(N=C3N1C2)N1C=CC(=N1)OCCC1C2(CC2)C21CC2 |
用途 |
Vanzacaftor is an orally active, novel cystic fibrosis transmembrane conductance regulator (CFTR) modulator. In combination with Tezacaftor and Deutivacaftor, it improves the processing and trafficking of the CFTR protein and enhances chloride transport. The Vanzacaftor-Tezacaftor-Deutivacaftor combination is safe and well-tolerated, and it improves lung function, respiratory symptoms, and CFTR function in patients with cystic fibrosis, showing promise for research and therapeutic applications in cystic fibrosis. |
InChIKey |
VCSUIBJKYCVWNF-NRFANRHFSA-N |